A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD)
NCT ID: NCT01344733
Last Updated: 2012-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
660 participants
OBSERVATIONAL
2011-05-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Depressive Symptoms in Acute Manic Episode
NCT00690248
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
NCT01663974
Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients
NCT01992302
Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up
NCT01255982
EVALUATION OF BLOOD BIOMARKER-BASED DIAGNOSTIC AID IN OUTPATIENTS SUFFERING FROM DEPRESSION
NCT06369805
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MDD
Patients with treatment resistant major depressive disorder will be evaluated in order to assess the presence of hypomanic symptoms as cause of resistance.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and Female age: 18-65 years
* Diagnosis of MDD according to DSM-IV TR (296.3 x Major Depressive Disorder, recurrent)
* Treatment resistance defined as non-response to at least 2 antidepressants given in an ade
Exclusion Criteria
* Patients unable to understand HCL-32 item meaning
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Mauro Carta
Role: PRINCIPAL_INVESTIGATOR
A.O.U. Universitaria di Cagliari
Dr. Gino Montagnani
Role: STUDY_CHAIR
Astrazeneca Italy
Dr. Raffaele Sabia
Role: STUDY_DIRECTOR
Astrazeneca Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Agrigento, AG, Italy
Research Site
Sciacca, AG, Italy
Research Site
Ancona, AN, Italy
Research Site
Corato, BA, Italy
Research Site
Putignano, BA, Italy
Research Site
Triggiano, BA, Italy
Research Site
Fasano, BR, Italy
Research Site
Bolzano, BZ, Italy
Research Site
Cagliari, CA, Italy
Research Site
Ortona, CH, Italy
Research Site
Cantù, CO, Italy
Research Site
Rogliano, CS, Italy
Research Site
Adrano-Bronte, CT, Italy
Research Site
Lamezia Terme, CZ, Italy
Research Site
Foggia, FG, Italy
Research Site
Firenze- ASL Di Firenze, FI, Italy
Research Site
Genova, GE, Italy
Research Site
Latina, LT, Italy
Research Site
Messina, ME, Italy
Research Site
Rho, MI, Italy
Research Site
Corleone, PA, Italy
Research Site
Palermo, PA, Italy
Research Site
Guidonia, RM, Italy
Research Site
Roma, RM, Italy
Research Site
Capaccio, SA, Italy
Research Site
Savona, SA, Italy
Research Site
Montecchio Maggiore, VI, Italy
Research Site
Castellammare di Stabia, , Italy
Research Site
Novara, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NIT-DUM-2010/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.